01 11ASTRAZENECA AB
01 118361972
01 11Blank
01 11Blank
01 112028-03-21
Patent Expiration Date : 2028-03-21
DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 8361972
Drug Substance Claim :
Drug Product Claim :
Application Number : 209091
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2028-03-21
Patent Expiration Date : 2028-03-21
US Patent Number : 8361972
Drug Substance Claim :
Drug Product Claim :
Application Number : 209210
Patent Use Code : U-2588
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-03-21
Patent Expiration Date : 2028-03-21
US Patent Number : 8361972
Drug Substance Claim :
Drug Product Claim :
Application Number : 202293
Patent Use Code : U-2139
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-03-21
Patent Expiration Date : 2028-03-21
US Patent Number : 8361972
Drug Substance Claim :
Drug Product Claim :
Application Number : 202293
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2028-03-21
Patent Expiration Date : 2028-03-21
US Patent Number : 8361972
Drug Substance Claim :
Drug Product Claim :
Application Number : 22200
Patent Use Code : U-2588
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-03-21
Patent Expiration Date : 2028-03-21
DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 8361972
Drug Substance Claim :
Drug Product Claim :
Application Number : 209091
Patent Use Code : U-1977
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-03-21
Patent Expiration Date : 2028-03-21
US Patent Number : 8361972
Drug Substance Claim :
Drug Product Claim :
Application Number : 202293
Patent Use Code : U-2139
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-03-21
Patent Expiration Date : 2028-03-21
DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 8361972
Drug Substance Claim :
Drug Product Claim :
Application Number : 209091
Patent Use Code : U-1976
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-03-21
Patent Expiration Date : 2028-03-21
US Patent Number : 8361972
Drug Substance Claim :
Drug Product Claim :
Application Number : 202293
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2028-03-21
Patent Expiration Date : 2028-03-21
US Patent Number : 8361972
Drug Substance Claim :
Drug Product Claim :
Application Number : 22200
Patent Use Code : U-2588
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-03-21
